Kuo HC - Search Results

1

Long-Term Surveillance and Management of Urological Complications in Chronic Spinal Cord-Injured Patients.

Wu SY, Jhang JF, Liu HH, Chen JT, Li JR, Chiu B, Chen SL, Kuo HC. Wu SY, et al. Among authors: kuo hc. J Clin Med. 2022 Dec 9;11(24):7307. doi: 10.3390/jcm11247307. J Clin Med. 2022. PMID: 36555924 Free PMC article. Review.

2

Quality of life after active urological management of chronic spinal cord injury in eastern Taiwan.

Kuo HC. Kuo HC. Eur Urol. 1998;34(1):37-46. doi: 10.1159/000019676. Eur Urol. 1998. PMID: 9676412

3

Re: Claus G. Roehrborn, Steven A. Kaplan, J. Stephen Jones, Joseph T. Wang, Tamara Bavendam, Zhonghong Guan. Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size. Eur Urol 2009;55:472-81.

Chung SD, Chiu B, Chuang YC, Kuo HC. Chung SD, et al. Among authors: kuo hc. Eur Urol. 2009 Feb;55(2):e30-1. doi: 10.1016/j.eururo.2008.08.031. Epub 2008 Aug 15. Eur Urol. 2009. PMID: 18718701 No abstract available.

4

Long-term outcomes of augmentation enterocystoplasty with an ileal segment in patients with spinal cord injury.

Chen JL, Kuo HC. Chen JL, et al. Among authors: kuo hc. J Formos Med Assoc. 2009 Jun;108(6):475-80. doi: 10.1016/S0929-6646(09)60095-4. J Formos Med Assoc. 2009. PMID: 19515628 Free article.

5

Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder.

Chung SD, Chiu B, Kuo HC, Chuang YC, Wang CC, Guan Z, Chancellor MB. Chung SD, et al. Among authors: kuo hc. BJU Int. 2010 Mar;105(5):668-72. doi: 10.1111/j.1464-410X.2009.08927.x. Epub 2009 Sep 29. BJU Int. 2010. PMID: 19793377

6

The efficacy of additive tolterodine extended release for 1-year in older men with storage symptoms and clinical benign proastatic hyperplasia.

Chung SD, Chang HC, Chiu B, Liao CH, Kuo HC. Chung SD, et al. Among authors: kuo hc. Neurourol Urodyn. 2011 Apr;30(4):568-71. doi: 10.1002/nau.20923. Epub 2011 Feb 22. Neurourol Urodyn. 2011. PMID: 21344494 Clinical Trial.

7

The therapeutic effects of repeated detrusor injections between 200 or 300 units of onabotulinumtoxinA in chronic spinal cord injured patients.

Chen YC, Kuo HC. Chen YC, et al. Among authors: kuo hc. Neurourol Urodyn. 2014 Jan;33(1):129-34. doi: 10.1002/nau.22395. Epub 2013 Mar 12. Neurourol Urodyn. 2014. PMID: 23494629 Clinical Trial.

8

Transurethral incision of the bladder neck improves voiding efficiency in female patients with detrusor underactivity.

Jhang JF, Jiang YH, Kuo HC. Jhang JF, et al. Among authors: kuo hc. Int Urogynecol J. 2014 May;25(5):671-6. doi: 10.1007/s00192-013-2279-4. Epub 2013 Nov 28. Int Urogynecol J. 2014. PMID: 24288115

9

Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.

Peng CH, Jhang JF, Shie JH, Kuo HC. Peng CH, et al. Among authors: kuo hc. Urology. 2013 Dec;82(6):1452.e1-6. doi: 10.1016/j.urology.2013.09.003. Urology. 2013. PMID: 24295265

10

Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.

Jhang JF, Jiang YH, Kuo HC. Jhang JF, et al. Among authors: kuo hc. Int J Urol. 2014 Apr;21 Suppl 1:49-55. doi: 10.1111/iju.12317. Int J Urol. 2014. PMID: 24807497 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,594 results

Search Page